Panretin

Active Ingredient(s): Alitretinoin
FDA Approved: * February 2, 1999
Pharm Company: * LIGAND
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Panretin Overview

Alitretinoin, or 9-cis-retinoic acid, is a form of vitamin A. It is also used in medicine as an antineoplastic (anti-cancer) agent developed by Ligand Pharmaceuticals. It is a first generation retinoid. Ligand gained Food and Drug Administration (FDA) approval for alitretinoin in February 1999. Contents 1 Medical uses 1.1 Kaposi’s sarcoma 1.2 Chronic hand eczema 2 Adverse effects 2.1 Adverse effects by frequency 2.2 Contraindications 2.3 Interactions 2.4 Overdose 3 Mechanism o...

Read more Panretin Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Alitretinoin

Recent Panretin Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Alitretinoin
  • Gel: 0.1%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Panretin: (1 result)

Sorted by National Drug Code
  • 62856-601 Panretin 60 mg/60g Topical Gel by Eisai Inc.

Other drugs which contain Alitretinoin or a similar ingredient: (1 result)

Related Panretin Topics:

panretin 30 mg price wallmart usa (alitretinoin)
Panretin 30 mg (alitretinoin) I would like to know the retail price of Panretin 30 mg please?...






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 17 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA